Kristen Ciombor, MD, MSCI, discusses the promise of liquid biopsies in the rapidly evolving metastatic colorectal cancer paradigm and the potential implications of the COLOMATE trial.
More From BioPortfolio on "Liquid Biopsy Screening Protocol Aims to Identify Actionable Targets in mCRC"